| Literature DB >> 31936264 |
Fan Li1, Yan Huang1, Kai Huang1, Jing Lin1, Peng Huang1.
Abstract
Magnetic graphene composites (MGCs), which are composed of magnetic nanoparticles with graphene or its derivatives, played an important role in sensors development. Due to the enhanced electronic properties and the synergistic effect of magnetic nanomaterials and graphene, MGCs could be used to realize more efficient sensors such as chemical, biological, and electronic sensors, compared to their single component alone. In this review, we first reviewed the various routes for MGCs preparation. Then, sensors based on MGCs were discussed in different groups, including optical sensors, electrochemical sensors, and others. At the end of the paper, the challenges and opportunities for MGCs in sensors implementation are also discussed.Entities:
Keywords: biological sensors; chemical sensors; electronic sensors; graphene; magnetic nanoparticles
Year: 2020 PMID: 31936264 PMCID: PMC7013569 DOI: 10.3390/ijms21020390
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Sensors based on the use of magnetic graphene composites.
| Preparation Method | Composite | Sensor Type | Analyte(s) | Linear Dynamic Range (LDR) | Limit of Detection (LOD) | Real Sample (s) | Citation |
|---|---|---|---|---|---|---|---|
| Ex situ non-covalent conjugation Assembly | CS/Fe3O4/GO/T-Apt/HM | Chemiluminescence | Thrombin | 5.0 × 10−15–2.5 × 10−10 M | 1.5 × 10−15 M | Serum | [ |
| BGNs- Fe3O4/Au-Ab1 | Electro-chemiluminescent immunoassay | Tetrodotoxin | 0.01–100 ng·mL−1 | 0.01 ng·mL−1 | Muscle samples | [ | |
| SPE/GS-Nafion/Fe3O4-Au-HRP | Electrochemical | H2O2 | 2.0 × 10−5–2.5 × 10−3 M | 1.2 × 10−5 M | Contact lens care solution | [ | |
| rGO-Fe3O4/SPE | Electrochemical | As(III) | 2–300 μg·L−1 | 0.10 μg L−1 | Lake, reverse osmosis and natural mineral water samples | [ | |
| HRP-GS-Fe3O4-CS/GC | Electrochemical | H2O2 | 2.49 × 10−5–1.67 × 10−3 M | 3.05 × 10−6 M | - | [ | |
| Fe3O4@PDA-rGO | Electrochemical immunoassay | Microcystin-LR | 0.01–50 mg·L−1 | 0.007 ug·L−1 | Real water | [ | |
| Fe3O4-GO | Photothermal Imaging | Cancer cell | 100–700 cells | 100 cells | Human Blood | [ | |
| Fe3O4@Chitosan/GO | Flame atomic absorption spectrometer (FAAS) | Lead ion Pb2+ | 10–800 ng·mL−1 | 2 ng·mL−1 | Blood | [ | |
| Ex situ covalent conjugation Assembly | Fe3O4-GO-hemin | Colorimetry | Glutathione (GSH) | 10−10–10−6 M | 8.2 × 10−11 M | Extraction of Ramos cells | [ |
| Pd/Fe3O4-PEI-rGO | Colorimetry | H2O2 | 0.5–150 × 10−6 M | 0.1 × 10−6 M | - | [ | |
| rGO-Fe3O4@Silance-rGO | Electrochemical | Europium metal ion | Differentialpulsestrippingvoltammetry (DPSV) (0.99–29.12 μg·L−1); | DPSV (0.30 μg·L−1); | Water, food, urine and human blood serum | [ | |
| Ag-Fe3O4-GO/GCE | Electrochemical | Nitrite | 0.5 × 10−6 M–0.72 × 10−3 M, 0.72–8.15 × 10−3 M | 0.17 × 10−6 M | Tap water | [ | |
| Fe3O4-rGO-GOx | Electrochemical | Glucose | 0.05–1 × 10−3 M | 0.1 × 10−6 M | - | [ | |
| Fe3O4-rGO | Electrochemical | Lobetyolin | 1.0 × 10−7–1.0 × 10−4 mol·L−1 | 4.3 × 10−8 M | Radix Codonopsis | [ | |
| Bio-Ab-Cor/AuNPs/ Fe3O4-rGO@Nafion/GCE | Electrochemical immunoassay | Cortisol | 0.1–1000 ng·mL−1 | 0.05 ng·mL−1 | Human serum | [ | |
| Fe3O4@SiO2-GO | Electrochemical immunoassay | Cancer antigen 153 | 10−3–200 U·mL−1 | 2.8 × 10−4 U·mL−1 | Serum | [ | |
| Fe3O4/GO@GSH | Zeta potential analyzer | As(III) | 0.5–1.5 mol·L−1 | 0.1 mg·L−1 | Tea samples | [ | |
| TETA-Fe3O4-GO | MSPE-LC-MS/MS | Estrogens | - | 0.15–1.5 ng·L−1 | Tap water, well river, river water | [ | |
| In situ Reduction | Fe3O4-Pd/3DRGO | Colorimetry | GSH/Glucose | 0.4–40 × 10−6 M/0.5–60 × 10−6 M | 5.2 × 10−8 M/1.3 × 10−7 M | Human urine | [ |
| Fe3O4/NG | Colorimetry | H2O2 and Glucose | 17.1 × 10−6 M–10 × 10−3 M | 17.1 × 10−6 M | - | [ | |
| Fe3O4/GO/PtNPs | Colorimetric | Breast cancer cells | 100–1000 cells | 100 cells | - | [ | |
| Aptamer- Fe3O4/GO | Fluorescent | Bisphenol A | 0.2–10 ng·mL−1 | 0.071 ng·mL−1 | Actual water | [ | |
| Fe3O4-Chitosan-GO | Fluorescence spectroscopy, | Bacterial cell | P.aeruginosa, 4–40 × 102 cfu·mL−1 | 1.0–4.0 × 102 cfu·mL−1 | Blood colloids | [ | |
| ILs-Fe3O4@DA/GO/β-CD | Chemiluminescence | Lysozyme | 1.0–80 × 10−9 mg·mL−1 | 3.0 × 10−10 mg·mL−1 | Human urine | [ | |
| Fe3O4/GO | Chemiluminescence | prostate specific antigen (PSA) | 1.6–50 ng·mL−1 | 0.5 ng·mL−1 | 25% human serum. | [ | |
| β-CD/Cs- Fe3O4/GO-SMIP | Chemiluminescence | Bovine serum albumin (BSA) | 5.0 × 10−7–1.0 × 10−4 mg·mL−1 | 1.1 × 10−7 mg·L−1 | - | [ | |
| Fe3O4/rGO-MWCNTs/SMIP | Chemiluminescence | Lysozyme | 5.04 × 10−9–4.27 × 10−7 g·mL−1 | 1.90 × 10−9 g·mL−1 | Eggs | [ | |
| Fe3O4/GO/IL/PBA | Chemiluminescence | Horseradish peroxidase | 1.0 × 10−4–8.0 × 10−3 mg·mL−1 | 2.9 × 10−5 mg·mL−1 | Waste water | [ | |
| Si/Fe3O4/GO/MIP | Chemiluminescence | Dopamine | 8.0–200.0 ng·mL−1 | 1.5 ng·mL−1 | Urine | [ | |
| Fe3O4/GO/Ag/AgCl | Chemiluminescence | Nitrite | 5–200 ng·mL−1 | 1.15 ng·mL−1 | Sausage | [ | |
| Fe3O4@POM/rGO/ Ru(bpy)32+ | Electro-chemiluminescent | Nicotinamide adenine dinucleotide (NADH), L-lactate dehydrogenase | 5 × 10−9 M–5 × 10−4 M for L-lactate | 0.1 × 10−9 M for NADH; | Serum | [ | |
| Fe3O4/GO | Electro-chemiluminescent | Thrombin | 2.0–50 × 10−9 mol·L−1. | 1.3 × 10−9 mol·L−1 | - | [ | |
| Fe3O4/GO/Ab2/Ru(bpy)32+ | Electro-chemiluminescent immunoassay | 3,30,5-triiodothyronine (T3) | 0.1 pg·mL−1–10 ng·mL−1 | 0.03 pg·mL−1 | - | [ | |
| Fe3O4/GNs | Electro-chemiluminescent immunoassay | PSA | 0.003–50 ng·mL−1 | 0.72 ng·mL−1 | Human serum | [ | |
| γ-Fe2O3/rGO | SERS 1 | R6G molecules | 5 × 10−7–5 × 10−4 M | 5 × 10−7 M | [ | ||
| Fe3O4/GO/Au | SERS 1 | Thiocyanate (SCN−) | - | 10−8 g·L−1 | Milk | [ | |
| Fe3O4/RGO | Electrochemical | Folate receptor | 0.01–100 ng·mL−1 | 7.8 pg·mL−1 | Pathological serum samples | [ | |
| Fe3O4/GO | Electrochemical | Pyrophosphatase | 0.1–20 mU·mL−1 | 0.05 mU·mL−1 | - | [ | |
| Fe3O4/GO | Electrochemical | Vascular endothelial growth factor (VEGF) | 31.25–2000 pg·mL−1 | 31.25 pg·mL−1 | Plasma | [ | |
| In situ Reduction | Fe3O4/GO/GC | Electrochemical | H2O2, | H2O2, 2 × 10−8–2.8 × 10−7 M; | H2O2, 6 × 10−9 M; | Real samples for Nitrite | [ |
| Fe3O4/GO | Electrochemical | Chromium (Cr+3) | 0.2–2 × 10−9 M | - | - | [ | |
| Fe3O4/GO/Gelatin | Electrochemical | glucose | 0.1–10 × 10−3 M | 0.024 × 10−6 M | Human blood | [ | |
| Fe3O4/GO/AChE | Electrochemical | Organophosphorus pesticide | 1–20 μg·L−1 | 0.18 μg·L−1 | - | [ | |
| FePc@ Fe3O4/rGO | Electrochemical | Tert-butyl hydroperoxide (TBHP) | 20 × 10−6 M–60 × 10−3 M | 7.5 × 10−6 M | Cosmetic sample | [ | |
| Fe3O4/GO/β-CD/GCE | Electrochemical | Tryptophan | 5.0 × 10−7 M–7.5 × 10−4 M | 3.1 × 10−7 M | - | [ | |
| Ni-PDA/CNTs/GO/ Fe3O4/CPE | Electrochemical | Salicylic acid (SA) | 5.00–155 × 10−6 M | 900 × 10−9 M | Water | [ | |
| Fe3O4/GO/CNT | Electrochemical | Diclofenac (DCF) | 100–1300 × 10−12 M | 33 × 10−12 M | Diclofenac sodium ampoule | [ | |
| Fe3O4/GQDs/GCE | Electrochemical | Amino acid | L-Cys (0.01–100 × 10−6 M); | L-Cys (0.01 × 10−6 M); | - | [ | |
| Fe3O4/rGO-GCE | Electrochemical | DNA sequences | 1.0 × 10−18–1.0 × 10−8 M | 2.8 × 10−19 M | Genomic samples extracted from blood | [ | |
| Fe3O4/rGO-GCE | Electrochemical | Phenylalanine | 100–1000 × 10−9 M | 14.5 × 10−9 M | - | [ | |
| Fe3O4/rGO/GOx-GCE | Electrochemical | Glucose | 0.05–1.5 × 10−3 M | 0.15 × 10−6 M | Human serum | [ | |
| Fe3O4@ZIF-8/rGO/GCE | Electrochemical | Dopamine | 2.0 × 10−9–1.0 ×10−5 M | 6.67 × 10−10 M | Urine and serum | [ | |
| β-CD- Fe3O4/rGO | Electrochemical | Tetracycline and doxycycline | 0.5–90.0 ng·L−1 | 0.18 ng·L−1 | Milk | [ | |
| In situ Reduction | Fe3O4/GQDs/MWCNTs/GCE | Electrochemical | Progesterone | 0.01–0.5 and 0.5–3.0 × 10−6 M | 2.18 × 10−9 M and 16.84 µA M−1 | Human serum | [ |
| UA/FePtGNR/SPCE | Electrochemical | Ampyra (4-aminopyridine or dalfampridine) | 0.08–9.0 × 10−6 M | 0.028 × 10−6 M | Biological fluids | [ | |
| β-CD/Au/Fe3O4/GO/GCE | Electrochemical | Sunset yellow | 5.0 × 10−9–2 × 10−6 M | 2 × 10−9 M | Water sample and mirinda drink | [ | |
| Fe3O4/GO/Ag/AuNPs/MIPs | Electrochemical | Dibutyl phthalate (DBP) | 2.5 × 10−9–5 × 10−5 M | 8 × 10−10 M | Drink samples | [ | |
| Fe3O4/GO/Chitosan | Electrochemical | Bisphenol A (BPA) | 6.0 × 10−8–1.1 × 10−5 M | 1.7 × 10−8 M | Plastic powder | [ | |
| S1-SA-Ab2-MFMGRS | Electrochemical immunoassay | Thyroxine | 0.05 pg·mL−1–5 ng·mL−1 | 0.015 pg·mL−1 | - | [ | |
| Fe3O4/rGO-Au@Ag/Ni2+-Ab2 | Electrochemical immunoassay | Carcinoembryonic antigen | 0.1 pg·mL−1–100 ng·mL−1 | 0.0697 pg·mL−1 | Human serum | [ | |
| Fe3O4/rGO/Au | Electrochemical immunoassay | Cluster of differentiation 146 antigen (CD146) | 5 pg·mL−1–500 ng·mL−1 | 2.5 pg·mL−1 | Human serum | [ | |
| Fe3O4/rGO-Au@Ag NPs | Electrochemical immunoassay | Human Immunoglobulin G | 5 fg·L−1–50 ng·mL−1 | 2 fg·L−1 | Human serum | [ | |
| MGLA/poly SiNW-FET | Electronic (FET) | Apolipoprotein A II protein (APOA2 protein) | 19.5 pg·mL−1–1.95 µg·mL−1 | 6.7 pg·mL−1 | Human urine | [ | |
| Ag@3D-Fe3O4/GO | MSPE-GC-µECD | Pesticides: Fenitrothion, Chloropyrofos, Hexaconazole | 0.1–5 ng·g−1 | 0.07–0.13 ng·g−1 | Extraction of the selected pesticides in tomato and grape samples | [ | |
| Fe3O4/GO | MSPE-HPLC-UV | Methamphetamine | 100–1500 ng·mL−1 | 30 ng·mL−1 | Urine samples | [ | |
| In situ Hydrothermal synthesis | Fe3O4/GO-CNT | UPLC-MS | Melamine | 0.0015–0.15 mg·kg−1 | 0.00045 mg·kg−1 | Milk | [ |
| Fe3O4/GO | Colorimetric | H2O2, | 1–50 × 10−6 M, | 0.32 × 10−6 M | Diabetic urine | [ |
1 SERS: Surface-enhanced Raman spectroscopy.
Figure 1Optical sensor-based MGCs: (a) Schematic diagram of colorimetric sensor example. Adapted with permission from ref. [32]. Copyright © 2015, American Chemical Society; (b) Schematic diagram of fluorescent sensor example. Adapted with permission from ref. [35]. Copyright © 2014, American Chemical Society; (c) Schematic diagram of SERS sensor example. Adapted with permission from ref. [47]. Copyright © 2013, Elsevier; (d) Schematic diagram of chemiluminescent sensor example. Adapted with permission from ref. [37]. Copyright © 2015, Royal Society of Chemistry.
Figure 2Schematic diagram of microfluidic chemical device for pyrophosphatase activity monitoring. Adapted with permission from ref. [55]. Copyright © 2015, American Chemical Society.
Figure 3Schematic diagram of electrochemical sensors for a norovirus-like particle. Adapted with permission from ref. [20]. Copyright © 2017, American Chemical Society.
Figure 4Novel sensors with photothermal way-based MGCs: (a) Schematic diagram of fabrication of the composite (b) Schematic diagram of photothermal sensor work process. Adapted with permission from ref. [12]. Copyright © 2016, American Chemical Society.